Clinical trial
The Effects of Aripiprazole on the Processing of Rewards in Schizophrenia
NCT00209027 · Emory University, Other · Terminated
Key facts
| NCT number | NCT00209027 |
|---|---|
| Title | The Effects of Aripiprazole on the Processing of Rewards in Schizophrenia |
| Official title | Aripiprazole Effects on Reward Processing in Deficit Syndrome Schizophrenia |
| Lead sponsor | Emory University, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug, Other |
| Interventions | fMRI, Aripiprazole |
| Enrollment | 20 |
| Start date | Apr 1, 2005 |
| Primary completion | Dec 1, 2010 |
| Completion | Apr 1, 2011 |
| First posted | Sep 21, 2005 |
| Last update posted | Dec 6, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: